Government-funded BiotechCorp Senior VP For Healthcare Selvam Ramaraj On Malaysia’s Biotech Expansion Plans: An Interview With PharmAsia News (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
Malaysiahas identified the biotechnology industry as one of the key drivers of growth in transforming the country into a knowledge-based economy, and the government is fully committed to its development. As part of that commitment, the government set up the Malaysian Biotechnology Corporation (BiotechCorp) in 2005, as one of the action plans under the National Biotechnology Policy, under the purview of the Ministry of Science, Technology and Innovation. BiotechCorp's goal is to identify value propositions in both R&D and commerce and support these ventures via financial assistance and other means. BiotechCorp Senior Vice President for Healthcare Selvam Ramaraj recently talked with PharmAsia News about the company and its master plans for Malaysia.
You may also be interested in...
Malaysia Biotechnology Sector Sees Opportunity With Economic Turndown, Challenge With Competing Neighbors
SHANGHAI - Malaysia's plans for its biotechnology sector remain ambitious even with the recent global meltdown
Malaysia Biotechnology Sector Sees Opportunity With Economic Turndown, Challenge With Competing Neighbors
SHANGHAI - Malaysia's plans for its biotechnology sector remain ambitious even with the recent global meltdown
ASEAN Signs MRA To Ensure All Exports Meet GMP Standards In Southeast Asia By 2011
HONG KONG - With an eye on developing a stronger regional pharmaceutical market, 10 countries in Southeast Asia are moving to eliminate trade barriers and improve drug safety by creating standard manufacturing and licensing processes
Need a specific report? 1000+ reports available
Buy Reports